Evidence map›Paper›PMID 38240629›Full record

ArticleLab on a chip2024

Scalable droplet-based radiosynthesis of [

Yingqing Lu, Jeffrey Collins, Kuo-Shyan Lin, R Michael van Dam

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Lab on a chip, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yingqing LuCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA, USA. mvandam@mednet.ucla.edu.ORCID 0000-0002-0343-5179
Jeffrey CollinsCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA, USA. mvandam@mednet.ucla.edu.
Kuo-Shyan LinDepartment of Molecular Oncology, BC Cancer Research Institute, Vancouver, British Columbia, Canada.ORCID 0000-0002-0739-0780
R Michael van DamCrump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA, USA. mvandam@mednet.ucla.edu.ORCID 0000-0003-2316-0173
University of California, Los Angeles · USUniversity of British Columbia · CA

Funding

Research Training in Biomedical PhysicsT32EB002101 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Michael F McNitt-Gray · 2003 to 2026
$5.3M
Accelerating the discovery and development of neurotracers via high-throughput radiochemistryR01EB032264 · NIBIB · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHATZIIOANNOU, ARION XENOFON, VAN DAM, ROBERT MICHAEL · 2022 to 2025
$2.7M
Optimization and validation of integrated microscale technologies for low-cost, automated production of PET molecular imaging tracers for cancer researchR33CA240201 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2019 to 2021
$1.1M
Radio-UPLC-MS for high-throughput analysis of short-lived radiolabeled compoundsS10OD026942 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI VAN DAM, ROBERT MICHAEL · 2019 to 2019
$199k
NCI NIH HHS R33 CA240201NIBIB NIH HHS R01 EB032264NIBIB NIH HHS T32 EB002101NIH HHS S10 OD026942
6 · The paper itself

Abstract

The [

Indexed as

Positron-Emission TomographyRadiopharmaceuticalsFluorine RadioisotopesRadiochemistryTissue DistributionFluorine RadioisotopesRadiopharmaceuticals

Identifiers

PMID38240629
PMCPMC10869106
OpenAlexW4390713344

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.